Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-09-02 00:00:00 ET · period of report 2025-08-28 · accession 0000097745-25-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-02 | 2025-08-28 | TMO | Lagarde Michel | EVP, COO | F - Tax | $489.74 | -961.20 | 23.9K | -4% | -$470.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-28 | F | D | 262.06 | $489.74 | 24,179.05 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-28 | F | D | 161.97 | $489.74 | 23,479.91 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-28 | F | D | 275.11 | $489.74 | 23,641.88 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-28 | F | D | 262.06 | $489.74 | 23,917 | D | — | — |